Northeast Investment Management Amgen Inc Transaction History

Northeast Investment Management

$2.18 Billion
Q3 2024

A detailed history of Northeast Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Northeast Investment Management holds 5,139 shares of AMGN stock, worth $1.42 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,139

Previous 5,269 2.47%

Holding current value

$1.42 Million

Previous $1.65 Million 0.55%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $40,219 - $43,859	-130 Reduced 2.47%	5,139 $1.66 Million
Q2 2024 Jul 26, 2024	SELL	$262.75 - $319.31 $40,726 - $49,493	-155 Reduced 2.86%	5,269 $1.65 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $15,594 - $18,824	-58 Reduced 1.06%	5,424 $1.54 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $51,140 - $57,691	-200 Reduced 3.52%	5,482 $1.58 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $54,662 - $67,865	250 Added 4.6%	5,682 $1.53 Million
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $160,488 - $189,774	-749 Reduced 12.12%	5,432 $1.21 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $46,738 - $56,966	-207 Reduced 3.24%	6,181 $1.49 Million
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 0.78%	6,388 $1.44 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $11,074 - $12,323	48 Added 0.75%	6,438 $1.57 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $14,033 - $15,524	-64 Reduced 0.99%	6,390 $1.55 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $24,860 - $28,450	-125 Reduced 1.9%	6,454 $1.45 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $81,087 - $95,003	-382 Reduced 5.49%	6,579 $1.4 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $3,106 - $3,620	-14 Reduced 0.2%	6,961 $1.73 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $89,636 - $99,682	382 Added 5.79%	6,975 $1.77 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $4,373 - $5,800	24 Added 0.37%	6,593 $1.34 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $25,164 - $32,345	-133 Reduced 1.98%	6,569 $1.58 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $452,757 - $530,733	2,716 Added 68.14%	6,702 $1.24 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $361 - $407	-2 Reduced 0.05%	3,986 $757,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $77,247 - $90,172	433 Added 12.18%	3,988 $776,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $15,193 - $17,128	-82 Reduced 2.25%	3,555 $737,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $332 - $373	2 Added 0.06%	3,637 $671,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $608,099 - $694,285	3,635	3,635 $678,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Account

Northeast Investment Management Amgen Inc Transaction History